| Financial Year |
March 31 2023 |
| Monetary Funds |
353,400,214.06 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
25,188,414.41 |
| Accounts Receivable |
3,920,974,662.03 |
| Advances to Suppliers |
27,026,363.74 |
| Other Receivables |
134,484,629.69 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,280,000.00 |
| Inventories |
214,038,453.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
485,076,246.23 |
| Other Current Assets |
288,447,947.70 |
| Total Current Assets |
6,967,630,709.28 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
4,512,091,388.61 |
| Long-term Equity Investment |
550,608,641.72 |
| Investment Properties |
36,275,632.66 |
| Fixed Assetes |
293,268,649.50 |
| Under-construction Projects |
61,975,448.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,098,127,552.14 |
| R&D expenses |
-- |
| Goodwill |
8,087,964.45 |
| Long-Term Deferred and Prepaid Expenses |
20,095,112.07 |
| Deferred Income Tax Assets |
215,092,471.90 |
| Other Non-Current Assets |
523,433,231.20 |
| Sub-Total of Non-Current Assets |
8,774,123,048.89 |
| Total Assets |
15,741,753,758.17 |
| Short-Term Loans |
1,392,681,963.31 |
| Trading Financial liabilities |
-- |
| Notes Payable |
45,917,238.28 |
| Accounts Payable |
2,028,677,206.57 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,117,582.45 |
| Taxes Payable |
70,774,414.54 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
202,711,160.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,356,034,948.88 |
| Other Current Liabilities |
345,312,956.28 |
| Sub-Total of Current Liabilities |
5,526,692,060.22 |
| Long-term Loans |
3,649,912,636.01 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
4,030,494.58 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
36,027.23 |
| Other Non-Current Liabilities |
512,924,811.00 |
| Sub-Total of Non-Current Liabilities |
4,427,104,209.38 |
| Total Liabilities |
9,953,796,269.60 |
| Paid-In Capital(Or Share Stock) |
1,604,242,081.00 |
| Capital Surplus |
281,628,859.88 |
| Surplus Reserve |
569,369,516.78 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,945,411,475.90 |
| Minority Stockholder's Interest |
742,156,819.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,045,800,669.18 |
| Owner's Equity（Stockholder's Equity） |
5,787,957,488.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,741,753,758.17 |
